Skip to main content

Table 1 Patient and disease characteristics

From: Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio

Age

 

   31–80 (Mean: 59)

 

Sex

 

   17 female 23 male

 

Disease

n

   Colorectal cancer

15

   Hepatocellular carcinoma

5

   Neuroendocrine tumors

10

   Breast cancer

4

   Lung cancer

2

   Endometrial cancer

1

   Ovarian cancer

1

   Unknown primary

2

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us